Highlights from DDW 2026
Featured
Myths, Facts, and Mysteries Surrounding the Gut Microbiome
In a packed session, moderators Carolina Tropini, from University of British Columbia and Elena Francisca Verdu, MD, from McMaster University led a lively discussion among panelists on the current state of gut microbiome clinical research and the future potential for diagnostic and therapeutic applications.
May 3 2026
Read moreRelated Articles
Latest Updates in Liver Disease
The AASLD track at DDW2026 featured several talks on new directions in liver disease pathology, treatment, and screening.
May 3 2026
Read moreHepatology Update for Gastroenterologists
An increasing number of patients with liver disease are seen by gastroenterologists rather than hepatologists. In this session, experts answered four practical questions that gastroenterologists may have about the diagnosis and referral of patients with metabolic dysfunction-associated steatotic liver disease (MASLD), primary biliary cholangitis (PBC), cirrhosis, and hepatocellular carcinoma (HCC).
May 3 2026
Read moreSpotlight on MetALD
In this session, an expert panel discussed metabolic dysfunction-associated alcohol-related liver disease (MetALD), a steatotic liver disease category defined as metabolic dysfunction-associated liver disease (MALSD) with elevated alcohol use, bringing together risk factors that interact to further elevate mortality risk.
May 3 2026
Read moreControversies in GERD Diagnosis and Management
A panel of experts reviewed some of the current topics and discussions about best practices in GERD.
May 3 2026
Read moreImproving Care Access and Navigation Among Underserved Patients
Disparities in access to gastroenterology and hepatology care persist in the U.S., and underserved patients are the most vulnerable to poor outcomes. In this session, speakers discussed the potential of digital tools, including AI, to address disparities and the importance of building trust with patients.
May 4 2026
Read moreHigh-Impact Papers in 2026
DDW invited the editors of leading journals in gastroenterology and hepatology to share some of the practice-changing research that was reported in the last year. David S. Weinberg, MD, MSC, from Fox Chase Cancer Center, and co-editor in chief of Gastroenterology, and Harmeet Malhi, MD, of Mayo Clinic, and the deputy editor of Hepatology, each shared four high-impact papers published in their journals.
May 4 2026
Read moreLooking Ahead: How Will We Manage IBD in 2030?
Leaders in IBD predicted changes that will occur in IBD research, diagnosis, and treatment over the next decade.
May 4 2026
Read moreDiagnoses and Disorders Mistaken for IBS
This session discussed the most common disorders that are mistaken for IBS—Ehler Danlos Syndrome (EDS), mast cell activation syndrome (MCAS), and postural orthostatic tachycardia (POTS)—and have overlapping symptoms and mechanisms of disease. These complex disorders affect the autonomic nervous system, immune response, and connective tissue function and are associated with disorders of gut-brain interaction (DGBI), requiring careful diagnosis.
May 4 2026
Read moreLate-breaking clinical science at DDW2026
Tuesday morning started with presentations of late-breaking clinical trial data in eosinophic esophagitis (EoE) and acute cholangitis.
May 5 2026
Read moreLate-breaking research in IBD
The morning continued with the presentation of late-breaking clinical trial findings specifically in inflammatory bowel disease (IBD).
May 5 2026
Read moreA new co-antibody therapy for UC and CD
Initial efficacy and safety of a first-in-class co-antibody therapy that targets both IL-23 and TNF alpha was presented by DUET-CD and DUET-UC trial investigators.
May 5 2026
Read moreNavigating Difficult Conversations in Clinical Practice
In this session, gastroenterologists described commonly encountered interactions with patients about disorders of gut-brain interaction (DGBIs) and how they approached these conversations with empathy and patience.
May 5 2026
Read more
© 2026 Wolters Kluwer. All right reserved.